437 related articles for article (PubMed ID: 24938626)
1. Age-related macular degeneration and changes in the extracellular matrix.
Nita M; Strzałka-Mrozik B; Grzybowski A; Mazurek U; Romaniuk W
Med Sci Monit; 2014 Jun; 20():1003-16. PubMed ID: 24938626
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).
García-Onrubia L; Valentín-Bravo FJ; Coco-Martin RM; González-Sarmiento R; Pastor JC; Usategui-Martín R; Pastor-Idoate S
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824762
[TBL] [Abstract][Full Text] [Related]
3. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO
Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
5. Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement.
Liva F; Cuffaro D; Nuti E; Nencetti S; Orlandini E; Vozzi G; Rossello A
Curr Drug Targets; 2019; 20(9):903-918. PubMed ID: 30666909
[TBL] [Abstract][Full Text] [Related]
6. Disturbed Matrix Metalloproteinases Activity in Age-Related Macular Degeneration.
Martins B; Fernandes R
Adv Exp Med Biol; 2023; 1415():21-26. PubMed ID: 37440009
[TBL] [Abstract][Full Text] [Related]
7. Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease.
Hussain AA; Lee Y; Marshall J
Prog Retin Eye Res; 2020 Jan; 74():100775. PubMed ID: 31473329
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
Padgett LC; Lui GM; Werb Z; LaVail MM
Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
[TBL] [Abstract][Full Text] [Related]
9. Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration.
Hussain AA; Lee Y; Zhang JJ; Marshall J
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4459-66. PubMed ID: 21498613
[TBL] [Abstract][Full Text] [Related]
10. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration.
Zeng R; Wen F; Zhang X; Su Y
Mol Vis; 2013; 19():729-36. PubMed ID: 23559867
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2194-200. PubMed ID: 9761302
[TBL] [Abstract][Full Text] [Related]
13. Retinal Distribution and Extracellular Activity of Granzyme B: A Serine Protease That Degrades Retinal Pigment Epithelial Tight Junctions and Extracellular Matrix Proteins.
Matsubara JA; Tian Y; Cui JZ; Zeglinski MR; Hiroyasu S; Turner CT; Granville DJ
Front Immunol; 2020; 11():574. PubMed ID: 32318066
[TBL] [Abstract][Full Text] [Related]
14. Bruch's membrane pathology: A mechanistic perspective.
Murali A; Krishnakumar S; Subramanian A; Parameswaran S
Eur J Ophthalmol; 2020 Nov; 30(6):1195-1206. PubMed ID: 32345040
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2.
Elliot S; Catanuto P; Stetler-Stevenson W; Cousins SW
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1696-702. PubMed ID: 16565411
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.
Mansoor N; Wahid F; Azam M; Shah K; den Hollander AI; Qamar R; Ayub H
Curr Mol Med; 2019; 19(10):705-718. PubMed ID: 31456517
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix and oxidative stress regulate human retinal pigment epithelium growth.
Eamegdool SS; Sitiwin EI; Cioanca AV; Madigan MC
Free Radic Biol Med; 2020 Jan; 146():357-371. PubMed ID: 31751761
[TBL] [Abstract][Full Text] [Related]
18. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
20. A local complement response by RPE causes early-stage macular degeneration.
Fernandez-Godino R; Garland DL; Pierce EA
Hum Mol Genet; 2015 Oct; 24(19):5555-69. PubMed ID: 26199322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
